Today (April 23), an internal email from Johnson & Johnson announced that Song Weiqun, Chairman of Johnson & Johnson China and President of Johnson & Johnson Medical Technology China, has tendered his resignation after careful consideration to pursue external development opportunities.
This news instantly "exploded" across the entire healthcare circle on social media. First, Song Weiqun, as the head of Johnson & Johnson in China, is highly influential in the industry. Second, Johnson & Johnson in China is at a crucial transition period—what changes will this sudden leadership change bring about in the future?
Johnson & Johnson was one of the first multinational companies to enter China after the reform and opening up.Song Weiqun, as the first China Chairman of Johnson & Johnson in its over 130-year history to have grown up locally, has also witnessed this magnificent journey.2024 marks the 21st year of Song Weiqun's dedication and work at Johnson & Johnson. In 2003, Song Weiqun joined Johnson & Johnson as a Global Management Trainee. In 2006, he returned to China to serve as the head of the Ethicon China Division of Johnson & Johnson Medical (China) Ltd. In 2015, he was promoted to President of Johnson & Johnson Medical China. Since 2018, he has concurrently served as Chairman of Johnson & Johnson China.He is courageous in taking responsibility, leading the Johnson & Johnson China President’s Council to promote the coordinated development of the company's three major businesses in China; with foresight, he was the first to propose positioning China as a "global innovation engine," making Johnson & Johnson the first Fortune 500 company to strategically deploy China as an innovation hub; he is committed to contributing to the health and well-being of 1.4 billion people in China and to the innovation and development of China's healthcare industry.Song Weiqun will continue to serve as the Chairman of Johnson & Johnson China and the President of Johnson & Johnson Medical Technology China until the end of September this year, overseeing all business operations and daily management to ensure a smooth transition and handover.Currently, its next development direction has not been disclosed to the public.
Follow us: CHC Medical Media
Report on the Development Trends of Medical Enterprises at Home and Abroad
Enterprise Investment, Financing, and M&A Events
Business Cooperation: 021-68581087
Or registration@chconsultant.com
